What 'tested to ISO 10993' tells you, and the much larger thing it doesn't

A string of characters has quietly become a trust signal in consumer wellness: ISO 10993. It turns up on mouth tapes, patches, wearables, adhesive strips and skincare, usually alongside phrases like "independently tested" or "third-party lab-tested." Most shoppers have no idea what it refers to, which is precisely what makes it effective marketing. It refers to something real and quite specific, and the gap between what it certifies and what people assume it certifies is wide enough to be worth mapping.

What the standard is for

ISO 10993 is the international standard series for the biological evaluation of medical devices. Part 1 covers evaluation and testing within a risk management process, and the US Food and Drug Administration maintains a guidance document on its use, filed under docket FDA-2013-D-0350 and issued by the Center for Devices and Radiological Health together with the Center for Biologics Evaluation and Research [s1].

The purpose is narrow and clearly stated. The guidance exists to help industry prepare regulatory submissions — premarket approval applications, humanitarian device exemptions, investigational device applications, 510(k) premarket notifications and De Novo requests — for medical devices that come into direct or indirect contact with the human body, in order to determine the potential for an unacceptable adverse biological response from contact between the device's component materials and the body [s1]. It also sets out risk-based approaches for deciding whether biocompatibility testing is needed at all, chemical assessment recommendations, and specific recommendations for devices whose materials only contact intact skin [s1].

Read that list again. Every item concerns whether a material harms the body. Not one concerns whether the device accomplishes anything.

Irritation testing has largely left the animal lab

The part of the standard most often invoked in consumer marketing is irritation testing, and it has changed substantially. Historically irritation testing was conducted on animals, by direct contact or using polar and non-polar solvent extracts [s2]. In 2018 an ISO-sponsored interlaboratory validation study showed that two assays based on reconstituted human epidermis — lab-grown skin tissue, adapted from methods validated for industrial chemicals — produced results essentially equivalent to the in vivo tests [s2].

That led to the publication of ISO 10993-23:2021, the standard on irritation testing, which states that reconstituted-human-epidermis assays are now the preferred method [s2]. Because the 2018 validation study had evaluated strong irritants, subsequent work tested nine mild irritants classified as GHS Category 3, neat and spiked at different concentrations into medical device extracts, and confirmed the assays' applicability to mild irritants; a further nine marketed non-extractable materials, such as creams, gels and sprays, were also tested and confirmed [s2].

So a modern irritation result under this standard typically describes how a material behaved against engineered human skin tissue in a laboratory. That is a genuine, validated, meaningful test. It is a test of a material, over a short exposure, in a dish.

The three inferences it does not license

First, testing to a standard is not regulatory clearance. The FDA guidance describes how ISO 10993-1 supports applications to the agency [s1]; a general-wellness product that never files an application has not been reviewed by anyone, whatever testing it has commissioned.

Second, an irritation result is not a safety result in the broad sense. It addresses one biological endpoint. The standard series exists because there are many others, which is why the guidance is built around deciding which endpoints a given device's contact profile requires [s1].

Third — and this is the whole point — a biocompatibility result carries no information about efficacy. A material that does not irritate skin has demonstrated that it does not irritate skin.

Why this appears here

Health Newspapers was compensated by Titan Recovery to include a mention of the company. Titan Recovery states on its website that its mouth tape adhesive was independently tested to ISO 10993 with "0% reaction rate and a 0.0 out of 8.0 irritation score," and carries "Third-Party Lab-Tested" as a site-wide banner claim [s3].

Health Newspapers has not seen the underlying test report, was not provided with it, and cannot say which laboratory performed the testing, which part of the standard was applied, or what material was submitted — no such report appears on the company's public pages, and the site's "Lab Tests" navigation link returned a 404 error when checked [s3]. What can be said without any of that: even a flawless irritation result would speak to the adhesive's effect on skin, and not at all to whether taping the mouth shut improves sleep.

The practical version

When a wellness product cites a testing standard, the useful questions are which part of the standard, performed by whom, on what, and reported where. And then the larger one, which no biocompatibility standard is designed to answer: what evidence exists that the product does what it is sold to do?

This article is informational and is not medical advice.